Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer
Midazolam can block the development of ovarian cancer, and the relevant mechanism may be realized through the ERK/JNK pathway.
Authors
- Xiaokun Sun
- Bing Fu (ORCID: https://orcid.org/0000-0002-5861-5708)
- Yun Zhang (ORCID: https://orcid.org/0000-0002-1358-6667)
- Haifang Yu
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- CytoJournal
- Published
- 2025-11-04
- DOI
- https://doi.org/10.25259/cytojournal_25_2025
- Citations
- 2
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 2.94